Operating Income (Loss) in USD of GB SCIENCES INC from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GB SCIENCES INC quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q4 2024.
  • GB SCIENCES INC Operating Income (Loss) for the quarter ending 31 Dec 2024 was -$66.6K, a 71.5% increase year-over-year.
  • GB SCIENCES INC Operating Income (Loss) for the twelve months ending 31 Dec 2024 was -$848K, a 46.3% increase year-over-year.
  • GB SCIENCES INC annual Operating Income (Loss) for 2023 was -$1.42M, a 15.1% increase from 2022.
  • GB SCIENCES INC annual Operating Income (Loss) for 2022 was -$1.67M, a 10.5% increase from 2021.
  • GB SCIENCES INC annual Operating Income (Loss) for 2021 was -$1.87M, a 6.64% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

GB SCIENCES INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$848K -$66.6K +$167K +71.5% 01 Oct 2024 31 Dec 2024 10-Q 12 Aug 2025
Q3 2024 -$1.02M -$158K +$394K +71.4% 01 Jul 2024 30 Sep 2024 10-Q 27 Nov 2024
Q2 2024 -$1.41M -$254K +$11K +4.14% 01 Apr 2024 30 Jun 2024 10-Q 27 Nov 2024
Q1 2024 -$1.42M -$370K +$160K +30.2% 01 Jan 2024 31 Mar 2024 10-K 30 Aug 2024
Q4 2023 -$1.58M -$234K +$173K +42.5% 01 Oct 2023 31 Dec 2023 10-Q 12 Aug 2025
Q3 2023 -$1.75M -$551K -$276K -99.9% 01 Jul 2023 30 Sep 2023 10-Q 27 Nov 2024
Q2 2023 -$1.48M -$265K +$194K +42.3% 01 Apr 2023 30 Jun 2023 10-Q 27 Nov 2024
Q1 2023 -$1.67M -$530K -$78.6K -17.4% 01 Jan 2023 31 Mar 2023 10-K 30 Aug 2024
Q4 2022 -$1.59M -$407K +$105K +20.6% 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024
Q3 2022 -$1.7M -$276K +$136K +33% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 -$1.83M -$460K +$33.9K +6.87% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$1.87M -$451K -$127K -39.1% 01 Jan 2022 31 Mar 2022 10-K 14 Jul 2023
Q4 2021 -$1.74M -$513K +$158K +23.5% 01 Oct 2021 31 Dec 2021 10-Q 03 Feb 2023
Q3 2021 -$1.9M -$412K +$80.3K +16.3% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$1.98M -$493K +$21.8K +4.24% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$2M -$324K +$874K +72.9% 01 Jan 2021 31 Mar 2021 10-K 30 Jun 2022
Q4 2020 -$2.88M -$670K +$803K +54.5% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022
Q3 2020 -$3.68M -$492K +$799K +61.9% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$4.48M -$515K +$1.26M +71% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$5.74M -$1.2M +$2.81M +70.1% 01 Jan 2020 31 Mar 2020 10-K 06 Jul 2021
Q4 2019 -$8.55M -$1.47M +$590K +28.6% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 -$9.14M -$1.29M +$2.1M +61.9% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$11.2M -$1.78M +$1.95M +52.3% 01 Apr 2019 30 Jun 2019 10-Q 02 Sep 2020
Q1 2019 -$13.2M -$4.01M +$2.13M +34.8% 01 Jan 2019 31 Mar 2019 10-K 28 Aug 2020
Q4 2018 -$15.3M -$2.06M +$4.16M +66.8% 01 Oct 2018 31 Dec 2018 10-Q 18 Feb 2020
Q3 2018 -$19.5M -$3.39M -$749K -28.3% 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019
Q2 2018 -$18.7M -$3.73M -$909K -32.2% 01 Apr 2018 30 Jun 2018 10-Q 15 Aug 2019
Q1 2018 -$17.8M -$6.14M -$3.83M -166% 01 Jan 2018 31 Mar 2018 10-K 15 Jul 2019
Q4 2017 -$14M -$6.22M -$3M -93.5% 01 Oct 2017 31 Dec 2017 10-Q 19 Feb 2019
Q3 2017 -$11M -$2.64M -$445K -20.3% 01 Jul 2017 30 Sep 2017 10-Q 16 Nov 2018
Q2 2017 -$10.5M -$2.82M -$1.61M -134% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$8.93M -$2.31M -$699K -43.3% 01 Jan 2017 31 Mar 2017 10-K 29 Jun 2018
Q4 2016 -$8.23M -$3.22M -$2.09M -185% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018
Q3 2016 -$6.15M -$2.2M +$496K +18.4% 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017
Q2 2016 -$6.64M -$1.21M +$315K +20.7% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$6.96M -$1.61M 01 Jan 2016 31 Mar 2016 10-K 14 Jul 2017
Q4 2015 -$1.13M -$451K -66.6% 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017
Q3 2015 -$2.69M 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$1.52M 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q4 2014 -$678K 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016
Q1 2012 -$103K -$6.12K +$16.5K +73% 01 Jan 2012 31 Mar 2012 10-K/A 20 Jul 2012
Q4 2011 -$119K -$18K +$61.7K +77.4% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2012
Q3 2011 -$181K -$21.9K +$37.9K +63.4% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 -$219K -$56.8K +$164K +74.3% 01 Apr 2011 30 Jun 2011 10-Q/A 13 Sep 2011
Q1 2011 -$383K -$22.7K 01 Jan 2011 31 Mar 2011 10-K/A 20 Jul 2012
Q4 2010 -$79.7K 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012
Q3 2010 -$59.9K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$221K 01 Apr 2010 30 Jun 2010 10-Q/A 13 Sep 2011

GB SCIENCES INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.42M +$252K +15.1% 01 Apr 2023 31 Mar 2024 10-K 30 Aug 2024
2022 -$1.67M +$196K +10.5% 01 Apr 2022 31 Mar 2023 10-K 30 Aug 2024
2021 -$1.87M +$133K +6.64% 01 Apr 2021 31 Mar 2022 10-K 14 Jul 2023
2020 -$2M +$3.74M +65.1% 01 Apr 2020 31 Mar 2021 10-K 30 Jun 2022
2019 -$5.74M +$7.45M +56.5% 01 Apr 2019 31 Mar 2020 10-K 06 Jul 2021
2018 -$13.2M +$4.63M +26% 01 Apr 2018 31 Mar 2019 10-K 28 Aug 2020
2017 -$17.8M -$8.89M -99.5% 01 Apr 2017 31 Mar 2018 10-K 15 Jul 2019
2016 -$8.93M -$1.97M -28.4% 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018
2015 -$6.96M +$1.02M +12.7% 01 Apr 2015 31 Mar 2016 10-K 14 Jul 2017
2014 -$7.97M 01 Apr 2014 31 Mar 2015 10-K 15 Jul 2016
2011 -$103K +$281K +73.2% 01 Apr 2011 31 Mar 2012 10-K/A 20 Jul 2012
2010 -$383K 01 Apr 2010 31 Mar 2011 10-K/A 20 Jul 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.